PDCO:NSD-Patterson Companies Inc (USD)

COMMON STOCK | Medical Distribution |

Last Closing

USD 21.96

Change

+0.22 (+1.01)%

Market Cap

USD 1.93B

Volume

0.49M

Analyst Target

USD 24.23
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Patterson Companies, Inc. engages in the distribution of dental and animal health products in the United States, the United Kingdom, and Canada. The company operates through three segments: Dental, Animal Health, and Corporate. The Dental segment offers consumable products, including infection control, restorative materials, and instruments; basic and advanced technology and dental equipment; and practice optimization solutions, such as practice management software, e-commerce, revenue cycle management, and patient engagement solutions, as well as clinical and patient education systems. This segment also provides a range of related services comprising software and design, maintenance and repair, and equipment financing services. The Animal Health segment distributes biologicals, pharmaceuticals, vaccines, parasiticides, diagnostics, prescription and non-prescription diets, nutritional's, consumable supplies, and equipment, as well as value-added services. This segment also provides private label portfolio of products to veterinarians, producers, and retailers under the Aspen, First Companion, and Patterson Veterinary brands. The Corporate segment offers customer financing services; and sells other miscellaneous products. It serves dentists, laboratories, institutions, other healthcare professionals, veterinarians, other animal health professionals, production animal operators, and animal health product retailers. The company was formerly known as Patterson Dental Company and changed its name to Patterson Companies, Inc. in June 2004. Patterson Companies, Inc. was founded in 1877 and is headquartered in Saint Paul, Minnesota.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-18 )

Largest Industry Peers for Medical Distribution

Symbol Name Price(Change) Market Cap
HSIC Henry Schein Inc

+1.22 (+1.71%)

USD 8.92B
AHG Akso Health Group ADR

+0.15 (+15.82%)

USD 0.22B
EDAP EDAP TMS SA

-0.07 (-2.22%)

USD 0.12B
YI 111 Inc

-0.05 (-7.69%)

USD 0.05B
COSM Cosmos Health Inc.

-0.03 (-2.63%)

N/A
ZYXI Zynex Inc

-0.01 (-0.12%)

N/A

ETFs Containing PDCO

KATZ:XETRA 7.02 % 0.00 %

N/A

N/A
PETZ:SW 7.02 % 0.00 %

N/A

N/A
PETZ:LSE 6.46 % 0.00 %

N/A

N/A
RNSC First Trust Small Cap US .. 2.20 % 0.60 %

-0.02 (0%)

USD 0.03B
ROSC Hartford Multifactor Smal.. 0.95 % 0.00 %

+0.10 (+0%)

USD 0.03B
DESD:LSE 0.00 % 0.00 %

N/A

N/A
DESE:LSE 0.00 % 0.00 %

N/A

N/A
WTEC:F 0.00 % 0.00 %

N/A

N/A
WTEC:XETRA 0.00 % 0.00 %

N/A

N/A
SDEI 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Medical Distribution) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -22.81% 57% F 30% F
Dividend Return 2.74% 100% F 62% D
Total Return -20.07% 71% C- 31% F
Trailing 12 Months  
Capital Gain -25.03% 57% F 29% F
Dividend Return 3.55% 100% F 54% F
Total Return -21.47% 57% F 31% F
Trailing 5 Years  
Capital Gain 24.49% 100% F 64% D
Dividend Return 29.48% 100% F 89% A-
Total Return 53.97% 100% F 72% C
Average Annual (5 Year Horizon)  
Capital Gain 10.51% 71% C- 67% D+
Dividend Return 14.37% 71% C- 70% C-
Total Return 3.86% 100% F 76% C+
Risk Return Profile  
Volatility (Standard Deviation) 33.86% 86% B+ 55% F
Risk Adjusted Return 42.43% 100% F 73% C
Market Capitalization 1.93B 80% B- 79% B-

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Underpriced compared to earnings

The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

Superior Dividend Growth

This stock has shown top quartile dividend growth in the previous 5 years compared to its sector

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector